Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

Mise à jour : Il y a 4 ans
Référence : NCT00273858

Femme et Homme

  • | Pays :
  • Greece
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This is a Phase 4 open label, non-interventional, multi-center study to evaluate the safety of Enbrel (etanercept) treatment in patients receiving etanercept 25mg sc twice weekly or 50mg of etanercept once weekly. The improvement of health-related quality of life will also be evaluated.


Critère d'inclusion

  • Ankylosing spondylitis ,Arthritis, Psoriatic ,Arthritis (rheumatoid) ,Spondylitis, Ankylosing

Liens